___
Halo Neuroscience raises $13m in Series B (Mass Device):
“Neurostimulation device maker Halo Neuroscience said today it raised $13 million in a Series B round of financing to support its Halo Sport neurostim headset designed to improve muscle memory acquisition from athletic training.
The funding round was led by TPG and joined by existing investors Lux Capital, JAZZ Venture Partners and XFund, the San Francisco-based company said…
The company’s flagship device, the Halo Sport, is designed to deliver neurostimulation to the motor cortex in a 20 minute neuropriming session which Halo Neuroscience claims induces a temporary state of hyperplasticity that allows neural pathways from the motor cortex to the muscles to be optimized and strengthened.”
News in Context:
- Important insights on the growing home use of tDCS brain stimulation: older-than-expected users, positive self-reported results for treatment of depression but negative for self-enhancement, and a couple areas of concern (severe burns, frequency)
- Study: Transcranial Direct Current Stimulation (tDCS) can reduce fatigue in patients with Multiple Sclerosis (MS)
- Next: How to navigate transcranial electrical stimulation claims and devices
- Presentation by Anna Wexler and others at the 2017 SharpBrains Virtual Summit:
All Hypnosis Feeds
via SharpBrains https://sharpbrains.com
No comments:
Post a Comment